Method of treating or preventing autoimmune uveoretinitis in mammals
AssigneesAutoimmune, Inc., The United States of America as represented by the Department of Health and Human Services
InventorsDavid Allen Hafler, Robert B. Nussenblatt, Alan G. Palestine, Howard L. Weiner
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of treating or preventing the clinical manifestation of an autoimmune disease having the symptoms of uveoretinitis in a mammal in need of such treatment comprising orally administering to said mammal an effective amount of an autoantigen, e.g., S antigen (S-Ag), and/or biologically active fragments, or analogs thereof specific for uveoretinitis. Also provided is a pharmaceutical formulation useful for treating or preventing uveoretinitis in mammals comprising an effective amount of one or more of the foregoing autoantigen, fragments or analogs.
Claims9
A method of treating the disease uveoretinitis in a human in need of such treatment by suppressing an autoimmune response associated with said disease, the method comprising orally or enterally administering to said human an amount effective to suppress said response of at least one member selected from the group consisting of (i) an autoantigen;
- and (ii) a fragment of said autoantigen which when orally administered elicits regulatory T-cells in said human that recognize said autoantigen or said fragment.
A method of treating the disease uveoretinitis in a human in need of such treatment by suppressing an autoimmune response associated with said disease, the method comprising orally or enterally administering to said human an effective amount for suppressing said response of at least one peptide selected from the group consisting of SRDKSVTIYLGNRDYIDHVS, VDPDLVKGKKVYVTLTCAFR, YGQEDVDVIGLTFRRDLYFS, PFLLTFPDYLPCSVMLQPAP, KSSVRYLIRSVQHAPLEMGP, ASSTIIKEGIDRTVLGILVS, GFLGELTSSEVATEVPFRLM, VATEVPFRLMHPQPEDPAKE, TSSEVATEVPFRLMHPQPED, SLTKTLTLVPLLANNRERRG, SLTRTLTLLPLLANNRERAG, KEGIDRTVLGILVSYQIKVKL KEGIDKTVMGILVSYQIKVKL, HVDDTDLYLTIPTARSVGAADGS and PTARSVGAADGSSWEGVGVVPDV.
A method of treating the disease uveoretinitis in a human in need of such treatment comprising orally or enterally administering to said human an amount of at least one member selected from the group consisting of (i) an autoantigen;
- and (ii) a fragment of said autoantigen which when orally administered elicits regulatory T-cells in said human, said amount being effective to accomplish at least one of (a) a decrease in stimulation index;
- (b) a decrease in inflammation of afflicted ocular tissue;
- (c) an improvement in visual acuity;
- (d) a reduction in cystoid macular edema;
- and (e) a decrease in the proliferative response of autoreactive T-cells of said human.
Dependencies are inferred from the claim text.